Siler K - Search Results

1

Phase I trial of iodine 131-labeled COL-1 in patients with gastrointestinal malignancies: influence of serum carcinoembryonic antigen and tumor bulk on pharmacokinetics.

Yu B, Carrasquillo J, Milenic D, Chung Y, Perentesis P, Feuerestein I, Eggensperger D, Qi CF, Paik C, Reynolds J, Grem J, Curt G, Siler K, Schlom J, Allegra C. Yu B, et al. Among authors: siler k. J Clin Oncol. 1996 Jun;14(6):1798-809. doi: 10.1200/JCO.1996.14.6.1798. J Clin Oncol. 1996. PMID: 8656248 Clinical Trial.

2

Therapeutic efficacy of a high-affinity anticarcinoembryonic antigen monoclonal antibody (COL-1).

Siler K, Eggensperger D, Hand PH, Milenic DE, Miller LS, Houchens DP, Hinkle G, Schlom J. Siler K, et al. Biotechnol Ther. 1993;4(3-4):163-81. Biotechnol Ther. 1993. PMID: 8292968

3

Therapeutic advantage of high-affinity anticarcinoma radioimmunoconjugates.

Schlom J, Eggensperger D, Colcher D, Molinolo A, Houchens D, Miller LS, Hinkle G, Siler K. Schlom J, et al. Among authors: siler k. Cancer Res. 1992 Mar 1;52(5):1067-72. Cancer Res. 1992. PMID: 1310638

4

Monoclonal antibody-based therapy of a human tumor xenograft with a 177lutetium-labeled immunoconjugate.

Schlom J, Siler K, Milenic DE, Eggensperger D, Colcher D, Miller LS, Houchens D, Cheng R, Kaplan D, Goeckeler W. Schlom J, et al. Among authors: siler k. Cancer Res. 1991 Jun 1;51(11):2889-96. Cancer Res. 1991. PMID: 1851665

5

Binding of radiolabeled MAb B72.3 administered intravenously and intraperitoneally in colorectal cancer patients. An overview.

Schlom J, Siler K, Colcher D, Carrasquillo JA, Reynolds JC, Sugarbaker P, Larson SM. Schlom J, et al. Among authors: siler k. Acta Radiol Suppl. 1990;374:123-8. Acta Radiol Suppl. 1990. PMID: 1966958 Review.

6

Radiolabeled monoclonal antibody B72.3 localization in metastatic lesions of colorectal cancer patients.

Colcher D, Carrasquillo JA, Esteban JM, Sugarbaker P, Reynolds JC, Siler K, Bryant G, Larson SM, Schlom J. Colcher D, et al. Among authors: siler k. Int J Rad Appl Instrum B. 1987;14(3):251-62. doi: 10.1016/0883-2897(87)90049-3. Int J Rad Appl Instrum B. 1987. PMID: 3667307

7

Biodistribution and preclinical radioimmunotherapy studies using radiolanthanide-labeled immunoconjugates.

Schott ME, Schlom J, Siler K, Milenic DE, Eggensperger D, Colcher D, Cheng R, Kruper WJ Jr, Fordyce W, Goeckeler W. Schott ME, et al. Among authors: siler k. Cancer. 1994 Feb 1;73(3 Suppl):993-8. doi: 10.1002/1097-0142(19940201)73:3+<993::aid-cncr2820731337>3.0.co;2-7. Cancer. 1994. PMID: 8306291

8

Advantage of dose fractionation in monoclonal antibody-targeted radioimmunotherapy.

Schlom J, Molinolo A, Simpson JF, Siler K, Roselli M, Hinkle G, Houchens DP, Colcher D. Schlom J, et al. Among authors: siler k. J Natl Cancer Inst. 1990 May 2;82(9):763-71. doi: 10.1093/jnci/82.9.763. J Natl Cancer Inst. 1990. PMID: 2182892

9

Tumor targeting with monoclonal antibody B72.3: experimental and clinical results.

Schlom J, Colcher D, Siler K, Thor A, Bryant G, Johnston WW, Szpak CA, Sugarbaker P, Carrasquillo JA, Reynolds JC, et al. Schlom J, et al. Among authors: siler k. Cancer Treat Res. 1990;51:313-35. doi: 10.1007/978-1-4613-1497-4_16. Cancer Treat Res. 1990. PMID: 1977453 Review. No abstract available.

10

Phase I radioimmunotherapy trial with iodine-131-CC49 in metastatic colon carcinoma.

Divgi CR, Scott AM, Dantis L, Capitelli P, Siler K, Hilton S, Finn RD, Kemeny N, Kelsen D, Kostakoglu L, et al. Divgi CR, et al. Among authors: siler k. J Nucl Med. 1995 Apr;36(4):586-92. J Nucl Med. 1995. PMID: 7699446 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters